Donor Lymphocyte Infusion from G-CSF-Primed, Unmanipulated Whole Blood Is Safe and Improves Chimerism in HLA-Matched and Haploidentical Transplantation
Conclusions: DLI obtained from unmanipulated, GCSF-primed whole-blood is a safe and affordable adoptive cell therapy. It is effective and improves mixed chimerism after HSCT, while it was less effective for overt relapse.DisclosuresGomez-Almaguer: AbbVie: Consultancy; Novartis: Consultancy.
Source: Blood - Category: Hematology Authors: Gomez-De Leon, A., Colunga Pedraza, P. R., Garcia-Camarillo, D. E., Vazquez-Garza, R. I., Santana-Hernandez, P., Gutierrez Aguirre, C. H., Cantu Rodriguez, O., Gomez-Almaguer, D. Tags: 723. Clinical Allogeneic and Autologous Transplantation: Late Complications and Approaches to Disease Recurrence: Poster III Source Type: research
More News: Acute Leukemia | Acute Lymphoblastic Leukemia | Acute Myeloid Leukemia | Cancer & Oncology | Chemotherapy | Chronic Leukemia | Chronic Myeloid Leukaemia | Filgrastim | Hodgkin's Disease | Leukemia | Lymphoma | Myelodysplastic Syndrome | Neulasta | Neupogen | Non-Hodgkin's Lymphoma | Prograf | Restasis | Tacrolimus | Transplants